To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.Official Title as Introduced
Legislative history2
Jul 20, 2026
HouseReferred to the House Committee on Energy and Commerce.